Valuation: Edwards Lifesciences Corporation

Market Cap 53.63B 46.47B 43.54B 39.71B 74.66B 5,116B 75.81B 512B 200B 2,561B 201B 197B 8,541B P/E 2026 *
36.8x
P/E 2027 * 28.2x
Enterprise Value 50B 43.32B 40.59B 37.02B 69.6B 4,769B 70.67B 477B 187B 2,388B 188B 184B 7,963B EV / Sales 2026 *
7.4x
EV / Sales 2027 * 6.52x
Free-Float
86.96%
Yield 2026 *
-
Yield 2027 * -
1 day-0.65%
1 week+4.59%
Current month+8.11%
1 month+0.91%
3 months+16.71%
6 months+21.73%
Current year+9.15%
1 week 88.6
Extreme 88.605
93.91
1 month 81.16
Extreme 81.155
93.91
Current year 74.66
Extreme 74.66
96.29
1 year 72.3
Extreme 72.3
96.29
3 years 58.93
Extreme 58.93
96.29
5 years 58.93
Extreme 58.93
131.73
10 years 27.04
Extreme 27.04
131.73
Manager TitleAgeSince
Chief Executive Officer 58 2023-05-10
Director of Finance/CFO 43 2026-05-28
Chief Tech/Sci/R&D Officer 51 2025-08-31
Director TitleAgeSince
Chairman 69 2024-05-06
Director/Board Member 62 2015-02-09
Director/Board Member 58 2023-05-10
Date Insider Type Main position Quantity % Market Cap.
7/30/26 Sell

Executive/Senior Manager

-146 0.0000%
7/28/26 Fiscal year

Executive/Senior Manager

28,884 0.0050%
7/27/26 Don

Chief Executive Officer

-3,561 0.0006%
Change 5-day change 1-year change 3-year change Capi.($)
-0.65%+4.59%+20.95%+17.18% 53.99B
-0.33%+4.36%+26.31%+10.89% 224B
-0.80%+3.07%+0.03%-19.43% 146B
+0.01%+6.95%-16.09%+31.78% 142B
+0.45%+7.71%-49.90%+0.76% 74.19B
-1.41%-0.54%-15.65%-17.29% 50.85B
-0.84%+5.05%+26.36%+16.85% 42.22B
+0.28%+4.04%+45.75%+42.68% 40.75B
-0.65%+2.90%-2.86%+0.96% 32.86B
+0.52%+0.88%-20.22%+25.93% 32.43B
Average -0.34%+3.90%+1.47%+11.03% 83.86B
Weighted average by Cap. -0.34%+4.41%+2.95%+8.99%

Financials

2026 *2027 *
Net sales 6.76B 5.86B 5.49B 5B 9.41B 645B 9.55B 64.53B 25.23B 323B 25.38B 24.83B 1,076B 7.43B 6.44B 6.03B 5.5B 10.34B 709B 10.5B 70.93B 27.73B 355B 27.89B 27.29B 1,183B
Net income 1.44B 1.24B 1.17B 1.06B 2B 137B 2.03B 13.7B 5.36B 68.54B 5.39B 5.27B 229B 1.9B 1.64B 1.54B 1.4B 2.64B 181B 2.68B 18.11B 7.08B 90.58B 7.12B 6.97B 302B
Net Debt -3.63B -3.15B -2.95B -2.69B -5.05B -346B -5.13B -34.67B -13.55B -173B -13.63B -13.34B -578B -5.19B -4.5B -4.22B -3.85B -7.23B -495B -7.34B -49.6B -19.39B -248B -19.5B -19.08B -827B
Logo Edwards Lifesciences Corporation
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (74%); - hemodynamic monitoring systems (9.1%); - other (16.9%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (25%), Japan (5.8%) and other (10.8%).
Employees
16,000
Date Price Change Volume
26-08-12 $93.05 -0.65% 2,340,304
26-08-11 $93.66 +1.77% 3,138,661
26-08-10 $92.03 +2.57% 4,443,994
26-08-07 $89.72 +0.45% 2,442,024
26-08-06 $89.32 +0.39% 2,655,569
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
93.05USD
Average target price
100.96USD
Spread / Average Target
+8.50%

Quarterly revenue - Rate of surprise